Last updated on July 2010

Study for adults with Hereditary Angioedema (HAE)


Brief description of study

Study for adults with Hereditary Angioedema (HAE)

Detailed Study Description

Winthrop University Hospital Clinical Trials Center is seeking volunteers with inadequately controlled Hereditary Angioedema (HAE) for a clinical research study to test a medication already approved by the Food and Drug Administration (FDA) to investigate the safety and effectiveness of a higher dosage not approved by the FDA.

Patient Inclusion Criteria: Eligible participants will receive study-related medication and medical care at no cost to them. Compensation travel expenses may also be available. Inclusion criteria:

  • diagnosis of HAE with a documented history of swelling
  • have a history of an average of more than one HAE attack each month of any severity
  • must be receiving the recommended CINRYZE™ (c1 Esterase Inhibitor [Human]) dosing of 1000 U every three to four days via intravenous injection

Patient Exclusion Criteria:

  • N/A

Clinical Study Identifier: TX134996

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Study Nurse

Winthrop University Hospital Clinical Trials Center
Mineola, NY USA
  Connect »